Supplement Adverse Event Reporting Readiness: The 15-Business-Day MedWatch 3500A Clock
The Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006 (DSHEA Title II) imposed on dietary supplement manufacturers, packers and distributors a mandatory reporting obligation for serious adverse events. The mechanics are simple on paper: any serious adverse event report (AER) received by the firm must be filed with FDA on MedWatch Form 3500A within 15 business days of receipt, with one-year recordkeeping of all serious and non-serious AERs. The mechanics are hard in practice because the 15-business-day clock starts at intake (not at triage), the evidence chain (lot, expiry, complaint narrative, medical assessment) has to be assembled inside the window, and most firms underestimate how much intake-side discipline that requires. This guide maps the workflow V5 runs to keep the clock honest.
What counts as a serious AER
MedWatch 3500A: what FDA actually wants in the form
The contact information rule: 21 CFR 111.1(e) and label compliance
The one-year recordkeeping rule and what FDA inspects
A 30-day AER readiness path
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Frequently asked
Does the 15-business-day clock start at intake or at triage?
Do non-serious AERs need to be reported?
Who is the "responsible person" for AER filing — manufacturer or brand-owner?
What records must we keep for an AER?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- Dietary Supplement cGMP Readiness: The V5 Hub
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- NDI Notification Readiness: 21 CFR 190.6 New Dietary Ingredient Dossier
- NSF 173 & USP <2750> Readiness: Third-Party Supplement Certification
- Structure/Function Claims Readiness: DSHEA §6, Disclaimers & Substantiation
- Supplement Identity Testing Readiness: 21 CFR 111 Subpart E
